Graph Neural Network Solutions for Biological Networks

Reduce the time to identify and validate novel drug targets from months to weeks by modeling complex protein-protein interaction networks and polypharmacology effects with high-precision GNNs. Integrates with existing assay data.

Improve prediction of Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties by up to 40% over traditional QSAR models using GNNs that capture molecular graph structure and metabolic pathway context.

Systematically evaluate lead compounds for off-target effects and potential toxicity by simulating their interaction with the human interactome, providing a systems-biology view that mitigates costly late-stage trial failures.

Engineer polypharmacological agents designed for complex diseases by leveraging GNNs to model multi-target interaction profiles, enabling rational design of molecules with balanced efficacy and safety profiles.

Move from single-target hypotheses to network-level disease understanding. Our GNN architectures integrate genomics, transcriptomics, and proteomics data to uncover novel pathway dysregulations and biomarker signatures.

Deploy with confidence using our production-grade MLOps pipelines for biological GNNs. Ensure full data lineage, model versioning, and reproducibility to meet internal QA and external regulatory standards like FDA/EMA guidelines.

Deploy GNNs to model disease-specific protein interaction networks, identifying novel, high-confidence therapeutic targets with polypharmacology profiles. Integrates with your existing assay data for rapid in-silico validation.

Predict multi-target drug effects and potential adverse reactions by modeling compound interaction with entire biological networks, moving beyond single-target analysis to understand system-wide impact.

Uncover emergent properties and causal relationships in gene regulatory and metabolic networks. Our GNNs interpret multi-omic data to reveal key drivers of disease phenotypes and potential intervention points.

Engineer GNNs to predict novel PPIs, characterize binding interfaces, and assess the impact of mutations on complex stability. Critical for understanding signaling cascades and designing protein therapeutics.

Apply graph-based learning to genomic sequences, optimizing CRISPR guide RNA design for maximum on-target efficiency and minimal off-target effects by modeling the cellular repair network context.

Model organism-specific metabolic networks as graphs to predict gene knockout/overexpression strategies. Optimize microbial chassis for yield, titer, and rate in synthetic biology applications.